Gazing into the scarlet crystal ball: Social work and Hepatitis C

British Journal of Social Work

Volumn 40, Issue 7, 2010, Pages 2291-2307

  Paylor, Ian ^a   Mack, Heather ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Drug use; Epidemic; Hepatitis C; Social work

Indexed keywords

EID: 78651295085     PISSN: 00453102     EISSN: 1468263X     Source Type: Journal    
DOI: 10.1093/bjsw/bcp136     Document Type: Article

References (60)

1. Aaron, S., McMahon, J. M., Milano, D., Torres, L., Clatts, M., Tortu, S., Mildvan, D. and Simm, M. (2008) 'Intranasal transmission of Hepatitis C: Virological and clinical evidence', Clinical Infectious Diseases, 47, pp. 931-4.
2. Advisory Council on the Misuse of Drugs (ACMD) (2009) The Primary Prevention of Hepatitis C Among Injecting Drug Users, London, Home Office.
3. All Party Parliamentary Group on Hepatology (APPGH) (2008) 'Divided nations: Tackling the Hepatitis C challenge across the UK', available online at www.hepctrust.org.uk/Resources/HepC/HCV%20Reports/APPHG%20Report%20- %20Divided%20Nations.pdf (accessed 5 August 2009).
4. Archer, L., Jones, N. and Willets, J. (2009) 'The Archer Inquiry: Independent public inquiry report on NHS supplied contaminated blood and blood products', available online at www.archercbbp.com/report.php (accessed 5 August 2009).
5. Blixen, C. E., Webster, N. J., Hund, A. J., Perzynski, A. T., Kanuch, S. W., Stoller, E. P., McCormick, R. A. and Dawson, N. V. (2008) 'Communicating about alcohol consumption with non harmful drinkers with Hepatitis C, patient and provider perspectives', Journal of General Internal Medicine, 23, pp. 1290-5.
6. Brener, L. and Treloar, C. (2009) 'Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: Implications for hepatitis C treatment', Australian Health Review, 33(1), pp. 100-7.
7. Butt, G., Patterson, B. L. and McGuiness, L. K. (2008) 'Living with the stigma of Hepatitis C', Western Journal of Nursing Research, 30, pp. 204-21.
8. Cancer Research UK (2009) 'UK liver cancer incidence statistics', available online at http://info.cancerresearchuk.org/cancerstats/types/liver/ incidence/ (accessed 13October 2009).
9. C-Level (2009) 'Who should be told when you have Hepatitis C?', available online at www.c-level.org.uk/downloads/factsheet23.pdf (accessed 1 August 2009).
10. Conrad, S., Garrett, L. E., Cooksley, W., Dunne, M. P. and Macdonald, G. (2006) 'Living with Hepatitis C means "you just haven't got a normal life anymore"', Chronic Illness, 2, pp. 121-31.
11. Crofts, N., Louie, R. and Loff, B. (1997) 'The next plague: Stigmatisation and discrimination related to the Hepatitis C virus infection in Australia', Health and Human Rights, 2, pp. 87-97.
12. Department of Health (2002) 'Hepatitis C strategy for England', London, Department of Health, available online at www.dh.gov.uk/dr-consum-dh/groups/dh- digitalassets/@dh/@en/documents/digitalasset/dh-4103282.pdf (accessed 1 August 2009).
13. Department of Health (2007) 'Social care and support for those living with Hepatitis C and affected by Hepatitis C', London, Department of Health, available online at www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/Browsable/DH-5026272 (accessed 1 August 2009).
14. Department of Health (2009a) 'Essential information for professionals and guidance on testing', available online at www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4097933 (accessed 1 August 2009).
15. Department of Health (2009b) 'Government response to Lord Archer's independent report on NHS supplied contaminated blood and blood products', available online at www.hepctrust.org.uk/Resources/HepC/HCV%20Reports/DOH/ Government%20response%20to%20Lord%20Archer%20Enquiry.pdf (accessed 1 August 2009).
16. Dolan, M. (1998) The Hepatitis C Handbook: Revised Edition, London, Catalyst Press.
17. DrugScope (2009) 'Awareness of Hepatitis C transmission risks low as new campaign launched', available online at www.drugscope.org.uk/newsandevents/ currentnewspages/Hep-C-awareness-campaign.htm (accessed 1 August 2009).
18. Ehsani, J., Trang, V. and Karvelas, M. (2006) 'Exploring the need for hepatology nurses and allied health professionals in Victorian liver clinics', Australian Health Review, 30(2), pp. 211-18.
19. Evans-Brown, M., Dawson, R. T., Chandler, M. and McVeigh, J. (2009) 'Use of melanotan I and II in the general population', BMJ, 338, pp. 566-8.
20. Foster, G. (2007) 'Symptoms of chronic infection with Hepatitis C', available online at www.hepctrust.org.uk/hepatitis-c/ Symptoms+of+chronic+infection+with+hepatitis+C.htm (accessed 1 August 2009).
21. Foster, G. (2008) 'Injecting drug users with chronic Hepatitis C: Should they be offered antiviral therapy?', Addiction, 103, pp. 1412-13.
22. Fraser, S. and Treloar, C. (2006) '"Spoiled identity" in hepatitis C infection: The binary logic of despair', Critical Public Health, 16, pp. 99-110.
23. Galindo, L., Wallace, G., Hansen, A. and Sylvestre, D. (2007) 'Education by peers is the key to success', International Journal of Drug Policy, 18, pp. 411-16.
24. Gow, P. J. and Mutimer, D. (2001) 'Regular review: Treatment of chronic Hepatitis C', British Medical Journal, 323, pp. 1164-7.
25. Harris, M. (2005) 'Living with Hepatitis C: The medical encounter', New Zealand Sociology, 20, pp. 4-19.
26. Health Protection Agency (2008) Hepatitis C in the UK: The Health Protection Agency Annual Report, London, Health Protection Agency Centre for Infections.
27. Hopwood, M. and Treloar, C. (2003) The 3D Project: Diagnosis, Disclosure and Discrimination-Living with Hepatitis C, Sydney, University of New South Wales.
28. Hopwood, M., Treloar, C. and Bryant, J. (2006) 'Hepatitis C and injecting-related discrimination in New South Wales, Australia', Drugs: Education, Prevention & Policy, 13, pp. 61-75.
29. Jenner, A. and Scott, A. (2007) 'Circulating beliefs, resilient metaphors and faith in biomedicine: Hepatitis C patients and interferon combination therapy', Sociology of Health & Illness, 30, pp. 197-216.
30. Mack, H. (2009) 'Exploring the responses of health and social care professionals to people living with Hepatitis C', undertaking a Ph.D. in Substance Misuse Symposium, Oxford Brookes University, 8 July 2009.
31. Mateu-Gelabert, P., Treloar, C., Catalund, V. A., Sandoval, M., Valderama-Zurian, J. C., Maher, L., Rhodes, T. and Friedman, S. R. (2007) 'How can Hepatitis C be prevented in the long term?', International Journal of Drug Policy, 18, pp. 338-40.
32. McNally, S., Temple-Smith, M., Sievert, W. and Pitts, M. (2006) 'Now, later or never? Challenges associated with Hepatitis C treatment', Australian and New Zealand Journal of Public Health, 30(5), pp. 422-7.
33. Mehta, S. H., Thomas, D. L., Sulkowski, M. S., Safaein, M., Vlahov, D. and Strathdee, S. A. (2005) 'A framework for understanding factors that affect access and utilisation of treatment for Hepatitis C virus infection among HCV mono infected and HIV/HCV coinfected injection drug users', AIDS, 19, pp. 179-89.
34. Miller, C. L., Tyndall, M., Spittal, P., Li, K., Papelu, A. and Schechter, M. T. (2002) 'Risk taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites and mobile needle exchanges', Journal of Urban Health, 79(2), pp. 257-65.
35. Munoz-Plaza, C. E., Strauss, S., Astone-Twerrell, J., Des Jarlais, D., Gwadz, M., Hagan, H., Osborne, A. and Rosenblum, A. (2008) 'Exploring drug users attitudes and decisions regarding Hepatitis C treatment in the US', International Journal of Drug Policy, 19, pp. 71-8.
36. National Institute for Clinical Excellence (2006) 'Peginterferon alpha with ribavirin for the treatment of mild chronic Hepatitis C', available online at www.nice.org.uk/nicemedia/pdf/TA106guidance.pdf (accessed 23 February 2009).
37. National Treatment Agency for Substance Misuse (NTA) (2008) 'Good practice in harm reduction', available online at www.nta.nhs.uk/publications/ documents/nta-good-practice-in-harm-reduction-1108.pdf (accessed 28 February 2009).
38. NHS Choices (2009a) 'FaCe It Hepatitis C best practice: Patient support', available online at www.nhs.uk/hepatitisc/SiteCollectionDocuments/pdf/patient- support.pdf(accessed 1 August 2009).
39. NHS Choices (2009b) 'FaCe It Hepatitis C best practice: Provision of care', available online at www.nhs.uk/hepatitisc/SiteCollectionDocuments/pdf/ provision-of-hepatitisc-care-in-durham.pdf (accessed 1 August 2009).
40. Paterson, B. L., Backmund, M., Hirsch, G. and Yim, C. (2007) 'The depiction of stigmatization in research about Hepatitis C', International Journal of Drug Policy, 18, pp. 364-73.
41. Paylor, I. and Orgel, M. (2004) 'Sleepwalking through an epidemic: Why social work should wake up to the threat of Hepatitis C', British Journal of Social Work, 34, pp. 897-906.
42. Personal Communication (2009) Discussion with Alternative Therapist, C-Level, Glasgow, July 2009.
43. Price, S. and Goyette, J. (2003) 'Role of psychiatrists in the care of patients with Hepatitis C and HIV/AIDS', Psychiatric Quarterly, 74(3), pp. 261-76.
44. Rhodes, T. and Treloar, C. (2008) 'The social production of risk among injecting drug users: A qualitative synthesis', Addiction, 103, pp. 1593-603.
45. Rhodes, T., Davis, M. and Judd, A. (2004) 'Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty', Addiction, 99, pp. 621-33.
46. Rodrigue, J. R. (2009) 'Impact of Hepatitis C virus infection in children and their caregivers: Quality of life, cognitive, emotional outcomes', Journal of Paediatric Gastroenterology and Nutrition, 48(3), pp. 341-7.
47. Royal College of General Practitioners (RCGP) (2007) 'Guidance on the prevention testing treatment and management of Hepatitis C in primary care', available online at www.smmgp.org.uk/download/guidance/guidance003.pdf (accessed 20 February 2009).
48. Simmonds, L. and Coomber, R. (2009) 'Injecting drug users: A stigmatised and stigmatizing population', International Journal of Drug Policy, 20, pp. 121-30.
49. Sutton, R. and Treloar, C. (2007) 'Chronic illness experiences, clinical markers and living with Hepatitis C', Journal of Health Psychology, 12(2), pp. 330-40.
50. Sylvestre, D. L. and Zweben, J. E. (2007) 'Integrating HCV services for drug users: A model to improve engagement and outcomes', International Journal of Drug Policy, 18, pp. 406-10.
51. Temple-Smith, M., Jenkison, K., Lavery, J., Gifford, S. M. and Morgan, M. (2006) 'Discrimination or discretion? Exploring dentists views on treating people with Hepatitis C', Australian Dental Journal, 51, pp. 318-23.
52. The Leith Agency (2006) 'Hepatitis C in Scotland: Attitudes and awareness among health professionals', available online at www.hepcscotland.co.uk/pdfs/ etahcin-scotland-attitudes-awareness-health-profess-2006-10.pdf (accessed 19 March 2009).
53. The Scottish Government (2008) 'Hepatitis C action plan for Scotland: Phase II: May 2008-March 2011', available online at www.scotland.gov.uk/ Resource/Doc/222750/0059978.pdf (accessed 1 August 2009).
54. Treloar, C. and Holt, M. (2008) 'Drug treatment clients' readiness for Hepatitis C treatment: Implications for expanding treatment services in drug and alcohol settings', Australian Health Review, 32(3), pp. 570-6.
55. Turning Point (2007) At the Sharp End: A Snapshot of 21st Century Injecting Drug Use, London, Turning Point.
56. Waller, L. (2004) 'Living with Hepatitis C: From self loathing to advocacy', Medical Journal of Australia, 180, pp. 293-4.
57. Webzell, I. (2008) 'Lifeline to change', Drink and Drugs News, July 2008, pp. 8-9.
58. White, B., Day, C., Thein, H., Doab, A., Bates, A., Holden, J., Van Beek, I. and Maher, L. (2008) 'Acceptability of Hepatitis C virus testing methods among drug users', Drug and Alcohol Review, 27, pp. 666-70.
59. Zacks, S., Beavers, K., Theodore, D., Doughtery, K., Batey, B., Shumaker, J., Galanko, J., Shreshtha, R. and Fried, M. (2006) 'Social stigmatisation and Hepatitis C virus infection', Journal Clinical Gastroenterology, 40(3), pp. 220-4.
60. Zickmund, S., Hills, S., Barnett, M., Ippolito, L. and Labreque, D. (2004) 'Hepatitis C virus infected patients report communication problems with physicians', Hepatology, 39(4), pp. 999-1007.